SGMO

#3170
Sangamo Therapeutics, Inc. Common Stock
0.43
-4.44%
Sector:
Básica:
Profit Currency:
Rango diario
0.43
0.43
Rango anual
0.35
1.07
Cambio diario
-4.44%
Monthly Change
+13.16%
6 month change
-20.37%
Cambio anual
-56.12%
Cierres anteriores
0.45
Open
0.43
Bid
Ask
Low
0.43
High
0.43
Volumen
17
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

Noticias